COVID-19: Updates on vaccines and therapeutics
Take a look at our day-by-day updates covering the latest on therapeutics and vaccines for COVID-19, from new partnerships to clinical trials..
Browsing: Drug Development
A peek behind the paper – Muhammad Faheem on dengue virus proteins as potential drug targets
Take a look behind the scenes of a recent Future Virology editorial entitled, ‘An insight into dengue virus proteins as potential drug/vaccine targets’, as we ask author Muhammad Faheem about recent advances in understanding dengue proteins and where the next 5–10 years could take us.
Competence-inhibiting drugs may prevent the spread of antibiotic resistance
Novel research suggests that some drugs may prevent the acquisition of resistance genes by preventing the induction of bacterial ‘competence’.
The race for COVID-19 treatments and vaccines: February’s industry headlines
Catch up on February’s industry headlines, including an MRSA breakthrough, a patent lawsuit, and the latest updates on the coronavirus outbreak and its impact on the biotechnology industry worldwide.
2020: A molecular odyssey – could artificial intelligence bring in a new age of antibiotic drug discovery?
Using machine-learning, researchers have discovered a new antibiotic that is able to kill bacteria resistant to other antibiotics.
FDA approves Merck & Co.’s Ebola vaccine Ervebo: January’s industry headlines
Take a look at the industry headlines from the last 2 months, including the FDA…
New compound reverses HIV latency in macaque models
Recently, a research collaboration has managed to reverse HIV latency in infected CD4+ T cells in mouse and macaque models, exposing them to the body’s immune response.
WHO prequalifies Ebola vaccine: November’s industry headlines
Take a look at this month’s industry headlines including results for Takeda’s dengue vaccine, approvals for Merck’s Ebola vaccine and the advent of a siderophore antibiotic – the first of this kind.
US FDA approves first rapid diagnostic test for Ebola: October’s industry headlines
Take a look at this month’s industry headlines including US FDA approvals for XOFLUZATM and…
A peek behind the paper – Shujuan Sun on using existing antibiotics as antifungals
Take a look behind the scenes of a recent Future Microbiology review, entitled ‘Anti-Candida activity of existing antibiotics and their derivatives when used alone or in combination with antifungals’ as we ask the authors about Candida infections, the potential repurposing of antibiotics and the future of this field.
